1. 320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer. (10th December 2020) Authors: Gandhi, Shipra; Forsyth, Peter; Opyrchal, Mateusz; Ahmed, Kamran; Khong, Hung; Attwood, Kristopher; Levine, Ellis; O'Connor, Tracey; Early, Amy; Fenstermaker, Robert; Prasad, Dheerendra; Takabe, Kazuaki; Czerniecki, Brian; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer. (9th November 2020) Authors: Gandhi, Shipra; Forsyth, Peter; Opyrchal, Mateusz; Ahmed, Kamran; Khong, Hung; Attwood, Kristopher; Levine, Ellis; O'Connor, Tracey; Early, Amy; Fenstermaker, Robert; Prasad, Dheerendra; Takabe, Kazuaki; Czerniecki, Brian; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed Glioblastoma. (5th November 2018) Authors: Ahluwalia, Manmeet; Reardon, David; Abad, Ajay; Curry, William; Wong, Eric; Peereboom, David; Belal, Ahmed; Qiu, Jingxin; Mogensen, Kathleen; Schilero, Cathy; Casucci, Danielle; Mechtler, Laszlo; Uhlmann, Erik; Ciesielski, Michael; Fenstermaker, Robert Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTIM-10. PHASE II STUDY OF PEMBROLIZUMAB PLUS SurVaxM FOR GLIOBLASTOMA AT FIRST RECURRENCE. (9th November 2020) Authors: Ahluwalia, Manmeet; Peereboom, David; Rauf, Yasmeen; Schilero, Cathy; Ciolfi, Marci; Ciesielski, Michael; Fenstermaker, Robert Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTIM-20. PROSPECTIVE RANDOMIZED PHASE II PLACEBO-CONTROLLED TRIAL OF SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA (SURVIVE). (14th November 2022) Authors: Ahluwalia, Manmeet; Ciesielski, Michael J; Abad, Ajay; Reardon, David A; Aiken, Robert; Barbaro, Marissa; Sinicrope, Kaylyn; Peereboom, David; Odia, Yazmin; Brenner, Andrew; Venur, Vyshak; Belal, Ahmed; Qiu, Jingxin; Khosla, Atulya; Schilero, Cathy; Casucci, Danielle; Mechtler, Laszlo; Fenstermak... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTIM-26. PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA. (14th November 2022) Authors: Ahluwalia, Manmeet; Ciesielski, Michael J; Reardon, David A; Abad, Ajay; Curry, William; Wong, Eric; Peereboom, David; Figel, Sheila; Hutson, Alan; Groman, Adrienne; Withers, Henry; Liu, Song; Belal, Ahmed; Qiu, Jingxin; Mogensen, Kathleen; Schilero, Cathy; Khosla, Atulya; Casucci, Danielle; Mech... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Imaging of Pituitary and Parasellar Disorders. Issue 5 (October 2016) Authors: Fenstermaker, Robert; Abad, Ajay Journal: Continuum Issue: Volume 22:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. INNV-16. CLINICAL APPLICABILITY OF INDIVIDUALIZED DRUG RESPONSE PROFILING UTILIZING EX-VIVO TISSUE-DERIVED 3D CELL CULTURE ASSAYS IN HIGH-GRADE GLIOMA: A SINGLE INSTITUTION CASE SERIES USING 3D-PREDICT RESULTS. (9th November 2020) Authors: Lipinski, Lindsay; Abad, Ajay; Mechtler, Laszlo; Fabiano, Andrew; Smith, Ashley; DesRochers, Teresa; Gevaert, Matthew; Vibat, Cecile Rose; Fenstermaker, Robert Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. INNV-33. FUNCTIONAL EX VIVO TESTING PROSPECTIVELY IDENTIFIES NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS SENSITIVE TO TEMOZOLOMIDE TREATMENT IRRESPECTIVE OF MGMT METHYLATION STATUS. (14th November 2022) Authors: DesRochers, Tessa; Lipinski, Lindsay; Abad, Ajay; Fenstermaker, Robert; Fabiano, Andrew; Edenfield, Jeffery; Kanos, Charles; Redjal, Navid; Rodriguez, Analiz; Mansouri, Alireza; Zacharia, Brad; Butowski, Nicholas; Jia-Xin Liu, Jesse; Han, Seunggu; Ziu, Mateo; Cohen, Adam; Smith, Ashley; Vibat, Ce... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OTME-21. The role of Glioblastoma associated mesenchymal stem cells in immune suppression. (5th July 2021) Authors: Dharma, Sanam Sahjram; Barone, Tara; Figel, Sheila; Birkemeier, Meaghan; Zhang, Yali; Fenstermaker, Robert; Ciesielski, Michael Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 2 Page Start: ii18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗